Characterization of Changes in PER.C6™ cellular metabolism during growth and propagation of a replication-deficient adenovirus vector

Biotechnology and Bioengineering

Volumn 90, Issue 5, 2005, Pages 645-655

  Maranga, Luis ^a   Auniņš, John G ^a   Zhou, Weichang ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PROTEIN DESIGN LABS INC   (United States)

Author keywords

Adenovirus; Cell metabolism; Medium exchange; PER.C6 cells

Indexed keywords

ADENOVIRUS; CELLULAR METABOLISM; VIRUS INFECTION; VIRUS PROPAGATION;

AMINO ACIDS; BIOREACTORS; CELL CULTURE; CELLS; CUTTER LOADERS; GLUCOSE; GROWTH KINETICS; PROTEINS; SUSPENSIONS (FLUIDS); SYNTHESIS (CHEMICAL); VIRUSES;

METABOLISM;

ADENOVIRUS VECTOR; ESSENTIAL AMINO ACID; LACTIC ACID;

ANALYTIC METHOD; ARTICLE; CELL METABOLISM; ENERGY METABOLISM; GLUCOSE INTAKE; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN SYNTHESIS; VIROGENESIS; VIRUS REPLICATION;

ADENOVIRIDAE; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; HUMANS; RETINA; VIRUS CULTIVATION; VIRUS REPLICATION;

ADENOVIRIDAE; MAMMALIA;

EID: 19544387789     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20455     Document Type: Article

References (35)

1. Bello LJ, Ginsberg HS. 1967. Inhibition of host protein synthesis in type 5 adenovirus-infected cells. J Virol 1:843-850.
2. Braithwaite AW, Russell IA. 2001. Induction of cell death by adenoviruses. Apoptosis 6:359-370.
3. Castilho LR, Medronho RA. 2002. Cell retention devices for suspended-cell perfusion cultures. Adv Biochem Eng Biotechnol 74:129-169.
4. Cote J, Garnier A, Massie B, Kamen A. 1998. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Biotechnol Bioeng 59:567-575.
5. Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC. 1998. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9:1909-1917.
6. Gilbert P-A, Garnier A, Jacob D, Kamen A. 2000. On-line measurement of green fluorescent protein (GFP) fluorescence for the monitoring of recombinant adenovirus production. Biotechnol Lett 22:561-567.
7. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74.
8. Henry O, Dormond E, Perrier M, Kamen A. 2004. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol Bioeng 86:765-774.
9. Iyer P, Ostrove JM, Vacante D. 1999. Comparison of manufacturing techniques for adenovirus production. Cytotechnology 30:169-172.
10. Johnson M, Lanthier S, Massie B, Lefebvre G, Kamen AA. 1996. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium. Biotechnol Prog 12:855-864.
11. Kamen A, Henry O. 2004. Development and optimization of an adenovirus production process. J Gene Med 6:S184-S192.
12. Lee YY, Yap MG, Hu WS, Wong KT. 2003. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production. Biotechnol Prog 19:501-509.
13. Ma L, Bluyssen HA, De Raeymaeker M, Laurysens V, van der Beek N, Pavliska H, van Zonneveld AJ, Tomme P, van Es HH. 2001. Rapid determination of adenoviral vector titers by quantitative real-time PCR. J Virol Methods 93:181-188.
14. Monica TJ, Montgomery T, Ayala JL, Schoofs GM, Whiteley EM, Roth G, Garbutt JJ, Harvey S, Castillo FJ. 2000. Monitoring adenovirus infections with on-line and off-line methods. Biotechnol Prog 16: 866-871.
15. Murakami P, Pungor E, Files J, Do L, Van Rijnsoever R, Vogels R, Bout A, McCaman M. 2002. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent e1-positive particles. Hum Gene Ther 13:909-920.
16. Nadeau I, Kamen A. 2003. Production of adenovirus vector for gene therapy. Biotechnol Adv 20:475-489.
17. Nadeau I, Jacob D, Perrier M, Kamen A. 2000a. 293SF metabolic flux analysis during cell growth and infection with an adenoviral vector. Biotechnol Prog 16:872-884.
18. Nadeau I, Sabatie J, Koehl M, Perrier M, Kamen A. 2000b. Human 293 cell metabolism in low glutamine-supplied culture: interpretation of metabolic changes through metabolic flux analysis. Metab Eng 2:277-292.
19. Nadeau I, Gilbert PA, Jacob D, Perrier M, Kamen A. 2002. Low-protein medium affects the 293SF central metabolism during growth and infection with adenovirus. Biotechnol Bioeng 77:91-104.
20. Raghunand N, Dale BE. 1999. Alteration of glucose consumption kinetics with progression of baculovirus infection in Spodoptera frugiperda cells. Appl Biochem Biotechnol 80:231-242.
21. Schoofs G, Monica TJ, Ayala J, Horwitz J, Montgomery T, Roth G, Castillo FJ. 1998. A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy. Cytotechnology 28:81-89.
22. Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG, Liu X, Nunnally MH, Sugarman BJ, Sutjipto S. 1997. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 8:453-465.
23. Shiver JW, Emini EA. 2004. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu Rev Med 55:355-372.
24. Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, et al. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immuno-deficiency-virus immunity. Nature 415:331-335.
25. Takagi M, Ilias M, Yoshida T. 2000. Selective retension of active cells employing low centrifugal force at the medium change during suspension culture of Chinese hamster ovary cells producing tPA. J Biosci Bioeng 89:340-344.
26. Takamatsu H, Hamamoto K, Ishimaru K, Yokoyama S, Tokashiki M. 1996. Large-scale perfusion culture process for suspended mammalian cells that uses a centrifuge with multiple settling zones. Appl Microbiol Biotechnol 45:454-457.
27. Tokashiki M, Takamatsu H. 1993. Perfusion culture apparatus for suspended mammalian cells. Cytotechnology 13:149-159.
28. Tokashiki M, Aral T, Hamamoto K, Ishimaru K. 1990. High density culture of hybridoma cells using a perfusion culture vessel with an external centrifuge. Cytotechnology 3:239-244.
29. van Wandelen C, Cohen SA, 1997. Using quaternary high-performance liquid chromalography eluent systems for separating 6-aminoquinolyl-N- hydroxysuccinimidyl carbamate-derivatized amino acid mixtures. J Chromatogr A 763:11-22.
30. Wu N, Ataai MM. 2000. Production of viral vectors for gene therapy applications. Curr Opin Biotechnol 11:205-208.
31. Wu SC, Huang GY, Liu JH. 2002. Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture. Biotechnol Prog 18:617-622.
32. Xie L, Pilbrough W, Metallo C, Zhong T, Pikus L, Leung J, Aunins JG, Zhou W. 2002. Serum-free suspension cultivation of PER.C6(R) cells and recombinant adenovirus production under different pH conditions. Biotechnol Bioeng 80:569-579.
33. Xie L, Metallo C, Warren J, Pilbrough W, Peltier J, Zhong T, Pikus L, Yancy A, Leung J, Aunins JG, Zhou W. 2003. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions. Biotechnol Bioeng 83:45-52.
34. Zhou W, Chen C-C, Buckland BC, Aunins JG. 1997. Fed-batch culture of recombinant NSO myeloma cells with high monoclonal antibody production. Biotechnol Bioeng 55:783-792.
35. Zhu J, Grace M, Casale J, Chang AT, Musco ML, Bordens R, Greenberg R, Schaefer E, Indelicato SR. 1999. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum Gene Ther 10: 113-121.